Will emerging pharmacotherapies improve the management of polycystic ovarian syndrome?

Expert Opin Emerg Drugs. 2016;21(1):1-4. doi: 10.1517/14728214.2016.1132701. Epub 2016 Jan 11.

Authors

Morena Luigia Rocca¹, Roberta Venturella¹, Rita Mocciaro¹, Fulvio Zullo¹, Michele Morelli¹

Affiliation

¹ a Unit of Obstetrics and Gynaecology, Department of Experimental and Clinical Medicine , 'Magna Graecia' University , Catanzaro , Italy.

PMID: 26667609
DOI: 10.1517/14728214.2016.1132701

No abstract available

Publication types

Editorial

MeSH terms

Adolescent
Adult
Drug Design*
Female
Humans
Polycystic Ovary Syndrome / drug therapy*
Polycystic Ovary Syndrome / epidemiology
Polycystic Ovary Syndrome / physiopathology
Young Adult